HYFT

MindWalk Holdings Corp.

Healthcare
Biotechnology
$61M market cap

Forecast run · Sep 14, 2026Upside rank 625 of 3,136

Model Signal

ForecastQ Daily Probabilities

52.7%

51.7%

29.9%

Analyst Consensus

Recommendation2.00/5 Buy

Last price$1.31

Price target$5.00

Implied move+283.1%

Analysts2

ForecastQ Portfolios

HYFT is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.